April 14, 2025 09:52 AM EDTUpdated 11:01 AM
News Briefing

Third Har­mon­ic to shut­ter; Fu­ture Pak once again tar­gets Ther­at­e­ch­nolo­gies

Ayisha Sharma

News Reporter

Plus, news about PRISM Bi­o­Lab and Elix:

Third Har­mon­ic Bio to shut down: The San Fran­cis­co-based biotech

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Trump pledges his sup­port for a change to the IRA long sought by drug­mak­ers

J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

Phar­ma tar­iffs could leave lit­tle room to hide with sweep­ing probe un­der­way

Sanofi’s Kymab-orig­i­nat­ed in­flam­ma­to­ry drug flunks mid-stage asth­ma tri­al

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times